Meet The Newest Team Members
Longtime followers of either New England Peptide or Peptides International are likely aware of the steady growth and changes that comes with a combined fifty-seven years in the industry. Now with recent expansions and merger, the unified company is poised for new positive developments with the addition of two of our newest members.
We are very pleased to announce that Martina Diekmann, Ph.D. has been appointed CEO and David Gavlik appointed CFO. The press release, available here, was made public on March 5th. Dr. Diekmann’s immediate duties include the integration of NEP and PI into one entity. She brings a wealth of knowledge, having held several global management positions in life sciences. David Gavlik’s experience of more than twenty-five years in financial operations, particularly with consolidation of acquired companies, is an exciting component of the team.
You can read more in the press release about their noteworthy backgrounds that are so suitable for this exciting period ahead.